0.00Open0.55Pre Close0 Volume106 Open Interest18.00Strike Price0.00Turnover4461.15%IV6.61%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-2DDays to Expiry0.55Extrinsic Value100Contract SizeAmericanOptions Type0.5153Delta0.2891Gamma31.64Leverage Ratio-262.0938Theta0.0000Rho16.30Eff Leverage0.0001Vega
Pulse Biosciences Stock Discussion
Pulse Biosciences, Inc. Announces Successful Treatment of Patients in First-in-Human Study With Its Nano-Pfa Cardiac Surgery System
1 MINUTE AGO, 8:00 AM EST
VIA BUSINESSWIRE
No comment yet